Evaluating triple therapy with lenvatinib, PD-1 inhibitor and transarterial chemoembolization for unresectable intrahepatic cholangiocarcinoma: A retrospective study. The efficacy and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results